Equities

Glenmark Pharmaceuticals Ltd

GLENMARK:NSI

Glenmark Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,649.80
  • Today's Change7.40 / 0.45%
  • Shares traded995.15k
  • 1 Year change+93.21%
  • Beta1.1527
Data delayed at least 15 minutes, as of Sep 19 2024 11:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue118,131115,832123,049
OPERATING EXPENSES
Cost of revenue total50,03046,98449,788
Selling, general and admin. expenses, total39,56336,23833,742
Depreciation/amortization5,8195,6924,867
Unusual expense(income)9,0107,6592,609
Other operating expenses, total16,58516,26116,251
Total operating expense121,006112,833107,258
Operating income(2875)3,00015,791
Other, net7,968320194
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes3652,39814,412
Provision for income taxes18,6733,2944,476
Net income after taxes(18309)(896)9,936
Minority interest(681)(802)(519)
Net income before extra. Items(18990)(1697)9,417
Total extraordinary items3,9734,670--
Net income(15017)2,9729,417
Inc.avail. to common excl. extra. Items(18990)(1697)9,417
Inc.avail. to common incl. extra. Items(15017)2,9729,417
EPS RECONCILIATION
Basic/primary weighted average shares282282282
Basic/primary eps excl. extra items(67)(6.01)33
Basic/primary eps incl. extra items(53)1133
Dilution adjustment------
Diluted weighted average shares282282282
Diluted eps excl. extra items(67)(6.01)33
Diluted eps incl. extra items(53)1133
COMMON STOCK DIVIDENDS
DPS - common stock primary issue2.502.502.50
Gross dividend - common stock705705705
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental4,8043,0872,486
SUPPLEMENTAL INCOME
Depreciation, supplemental6,3086,1133,320
Total special items8,9947,6012,674
NORMALISED INCOME
Normalized income before taxes9,35910,00017,086
Effect of special items on income taxes3,1482,660830
Income tax excluding impact of special items21,8215,9545,306
Normalized income after tax(12462)4,04511,780
Normalized income avail. to common(13144)3,24411,261
Basic normalized EPS(47)1140
Diluted normalized EPS(47)1140
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.